Palliative- and non-palliative indications for glucocorticoids use in course of immune-checkpoint inhibition. Current evidence and future perspectives

•Glucocorticoid (GC) prescription is frequent in advanced cancer patients.•GC usage may affect clinical outcomes of immunotherapy (IT).•In advanced cancer patients treated with IT, palliative indications to GC use may relate to inferior clinical outcomes. Immune-checkpoint inhibitors significantly r...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Critical reviews in oncology/hematology 2021-01, Vol.157, p.103176-103176, Article 103176
Hauptverfasser:	Marinelli, Daniele, Giusti, Raffaele, Mazzotta, Marco, Filetti, Marco, Krasniqi, Eriseld, Pizzuti, Laura, Landi, Lorenza, Tomao, Silverio, Cappuzzo, Federico, Ciliberto, Gennaro, Barba, Maddalena, Vici, Patrizia, Marchetti, Paolo
Format:	Artikel
Sprache:	eng
Schlagworte:	Cancer Glucocorticoids Glucocorticoids - therapeutic use Humans Immune Checkpoint Inhibitors Immune-checkpoint blockade Immunotherapy Neoplasms - drug therapy Palliative Care
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!